Vote for BP.Net for the 2013 Forum of the Year! Click here for more info.

» Site Navigation

» Home
 > FAQ

» Online Users: 905

2 members and 903 guests
Most users ever online was 6,337, 01-24-2020 at 04:30 AM.

» Today's Birthdays

None

» Stats

Members: 75,077
Threads: 248,523
Posts: 2,568,612
Top Poster: JLC (31,651)
Welcome to our newest member, jpriebe2
Results 1 to 4 of 4
  1. #1
    BPnet Veteran Ax01's Avatar
    Join Date
    06-14-2015
    Location
    Emerald City
    Posts
    6,183
    Thanks
    2,581
    Thanked 6,152 Times in 3,380 Posts

    Two New Methods for Helping the Fight Against Venomous Snakebites

    some guy in AZ was recently bitten by a rattler while enjoying the great outdoors and he was the first snakebite patient to receive a new type of antivenin. this new drug is an improvement as it helps in the phase 2/recovery part from a venomous snakebite where complications and late internal bleeding may occur. it's not cheap tho, but we don't expect it to be. $3000 per vial and takes about 12 vials for a complete treatment. so it's a big hospital bill w/o the cost of care and stay factored in, but it can save your life and/or appendages.

    article here: https://www.azcentral.com/story/news...om/3062483002/
    Phoenix man is first in the U.S. to receive new rattlesnake anti-venom

    Phoenix welder Samuel Evans unexpectedly became a medical celebrity after he was bitten on his right thumb by a rattlesnake while hiking Sunday in White Tank Mountain Regional Park.

    Outside of clinical trials, Evans is the first patient in the United States to be treated with a new rattlesnake anti-venom that hit the market in October, when rattlesnakes were not in season. As a result, no patients were treated with the product when it first came out.

    Banner-University Medical Center Phoenix, where Evans was treated this week, usually sees between 55 and 70 patients with rattlesnake bites per year.

    Though April is usually the beginning of the season, the hospital has already treated a few bites this year.

    Doctors now have a choice of two anti-venoms when treating patients bitten by rattlesnakes: the drug CroFab, and now Anavip, which was used to treat Evans. Doctors gave the Anavip to Evans intravenously after he had an allergic reaction to CroFab.

    Anavip is licensed by Tennesee-based Rare Disease Therapeutics Inc., which confirmed Tuesday that Evans appears to be the first patient to try Anavip outside of clinical trials.

    Officials with Rare Disease Therapeutics are hoping the anti-venom helps move science forward in treating rattlesnake bites, company medical science liaison Jude McNally said.


    Rattlesnake bites can cause dangerous delayed bleeding complications
    Anavip has a longer "half-life" than CroFab, meaning it stays in the body longer and reduces the chances of late bleeding complications, said Dr. Ayrn O'Connor, fellowship director of the medical toxicology program at the University of Arizona College of Medicine-Phoenix.

    "Fortunately, we now have another anti-venom available in the U.S. that's been FDA-approved," O'Connor said. "This is a relatively new product and the old product is still out there. ... Eventually, I think you will see that transition to where more and more Anavip is being used because of that benefit of being able to treat bleeding abnormalities and maintain that protection because it stays around in the body longer than the older product."

    When one is bitten by a rattlesnake, there's an immediate threat. But problems can happen hours and days after the bite, too. Strokes and even deaths occur due to delayed bleeding abnormalities, O'Connor said.

    "If this does take care of that problem as expected, it would reduce the risk of death from a delayed bleeding," O'Connor said of Anavip.

    Takeaway lesson: Don't touch, play with or handle rattlesnakes
    Rattlesnake bites not only cause pain, swelling and bleeding abnormalities. They can also cause tissue loss, restrictive injuries, amputations and "systemic toxicity" where blood pressure drops and the patient can become unconscious.

    "The number one take-home message is If you see a snake out in the wild, to not touch it, pick it up or play with it," O'Connor said. "We have historically had patients bitten in the face, often because they are handling a snake inappropriately."

    About 8,000 venomous snakebites occur in the U.S. each year, and those bites typically result in eight to 15 deaths, the University of Arizona Poison and Drug Information Center says.

    Evans, 44, so far has reacted positively to the Anavip and is hoping to be released from the hospital later this week.

    Evans was bitten toward the end of his Sunday afternoon hike as he used a stick to get a rattlesnake off the trail. He'd seen some kids looking at the snake, which was about three and a half feet long, and wanted to make sure no one got hurt, he said.

    "I grabbed a stick to get the snake off the trail to get it out of the way of the kids. It ended up getting caught up in the brush and got a little bit of leverage on it and he spun around and bit me," Evans said from his hospital bed Tuesday.

    None of the kids were bitten and Evans used his own bite as a teachable moment, he said.

    "After it happened I told the kids, 'this is why you don't mess with them (snakes)'," Evans said. "I told them to learn from my mistake."

    A bite out of your wallet: One vial of Anavip is about $1,200
    The bite itself wasn't too painful, more like a slap. But the swift swelling was not a good sign. Evans knows a thing or two about rattlesnake bites — this was his fifth, though it has been a while since the last one, in 2005.

    He admits being fascinated by snakes. If he sees one, he'll always stop and look, he said. Most people get scared off after one bite, but Evans said it hasn't stopped him from going outdoors.

    "I'm out in the wilderness all the time, constantly hiking," he said. "This time of year they (rattlesnakes) are active all day long. The temperatures are perfect for them. They don't like it cold. They don't like extreme heat."

    Initially, Evans went to a hospital near the trail and received CroFab, and that hospital transferred him to Banner-University Medical Center Phoenix near downtown, where he received more CroFab. But that's when he broke out in hives and a rash.

    "That's when they put me on this new stuff. I knew they said it was new, but I didn't know it was that new...My girlfriend keeps teasing me about being famous," he said. "It seems to be working very well. I was anticipating this being much worse overall."

    Evans did not have health insurance at the time of the bite but is hoping to get covered through an application he submitted to the Arizona Health Care Cost Containment System, which is the state's Medicaid program.

    "If I don't get it I'll be paying for this for a very, very long time," he said.

    Indeed, snakebites can be expensive. One vial of CroFab is about $3,000 and one vial of Anavip is about $1,200, O'Connor said, citing the most recent estimates she has seen. Treatment usually requires on average more than 12 vials, and that does not include the cost of hospitalization and other care.

    "It's very expensive therapy but this is a relatively rare diagnosis and in the long run, it ends up being about half the cost to treat a patient with Anavip compared to CroFab," she said.
    RIP Mamba
    ----------------

    Wicked ones now on IG & FB!6292

  2. The Following 2 Users Say Thank You to Ax01 For This Useful Post:

    Bogertophis (03-06-2019),Dianne (03-06-2019)

  3. #2
    BPnet Veteran Ax01's Avatar
    Join Date
    06-14-2015
    Location
    Emerald City
    Posts
    6,183
    Thanks
    2,581
    Thanked 6,152 Times in 3,380 Posts
    the 2nd kind will use polymer nanoparticles or something to absorb and neutralize the venom. they hope to deliver it in an epipen type form which will be cool and useful to have on hikes and stuff.

    article here: https://blog.nature.org/science/2019...-by-snake-bite
    Could Nanoparticles Save Thousands From Death By Snake Bite?

    You may only have as little as a couple hours, give or take, from the moment a western diamondback rattlesnake pierces your skin to when you need to be in a hospital bed hooked to antivenom.

    In the world of snake venom treatment, there’s a saying for this: “Time is tissue.” Every minute that passes more cells perish, increasing the risk for lost appendages and possible death. The story is the same with other venomous snakes across the planet. But anyone spending time deep in the wilderness knows a few hours just isn’t that long.

    An unusual pairing of researchers – a chemist from California and a snake venom expert from Costa Rica – hope to one day create a solution to that short time gap between infection and death, venom and tissue damage: Think EpiPen for snake bites.

    Even at its most promising, it likely wouldn’t replace the need for antivenoms, the researchers say. But it could take that short window and extend it much longer and prevent lost appendages along the way. And unlike many failed experiments in treating snake bites, their research was published recently in PLOS Neglected Tropical Diseases showing success in lab mice.

    A Tale of Two Scientists
    José María Gutiérrez and Kenneth Shea come from wildly different academic worlds. Shea is a chemistry professor working in a lab at the University of California, Irvine studying nanotechnology. Gutiérrez is a snake expert at the University of Costa Rica, collaborating with health organizations around the globe to create antivenoms.

    In late 2016, those worlds came together. The basic idea is this: Create synthetic nanoparticles that can be injected into the site of a snake bite and essentially function as a sponge, targeting, mopping up and surrounding deadly snake proteins before they spread through the body.

    Shea’s lab had been working with the interaction of synthetic nanoparticles and biological macromolecules (basically microscopic bits that are human-made and nature-made) for more than a decade. He realized through the course of many years that his lab could create synthetic polymers that would bind to and inhibit biological proteins.

    “Once in the clutches of a nanoparticle, you neutralize the toxin’s activity,” Shea says. But he knew very little about snake bites and venom. Before his lab could proceed much farther, they needed to collaborate with someone who worked with snakes directly and understood their complex toxins.

    Enter the Instituto Clodomiro Picado, where Gutiérrez has been working with snake venoms and antivenoms for decades.

    “We were finishing a study on how the spitting cobra initiates this terrible tissue damage, and we were studying the action of the venom and trying to search for therapeutic solutions to the problem,” Gutiérrez says.

    Shea sent a sample of nanoparticles that bind to spitting cobra venom to Costa Rica. Gutiérrez tried them in his lab.

    They worked.

    The Stopgap
    Antivenoms are both a miracle cure and a finicky, hyper-specific Hail Mary. If a western diamondback rattlesnake strikes your leg, and you arrive at a hospital soon enough, and that hospital has that antivenom (which can expire) on hand, and has trained medical staff who can administer it, you will survive.

    If any of those go wrong however – you miss your window, the hospital doesn’t carry that particular antivenom, or doesn’t have trained staff to administer it – you may well die. Venoms are a toxic cocktail for a reason, Shea says.

    “The prey is small mammals, and small mammals have immune systems, so eventually if snakes were to have a single toxin and not a complicated mixture, they would develop an immunity,” he says.

    The result is a toxin that, as of right now, can really only be fought thoroughly by using antibodies created after injecting venom into livestock. That system, while perfect for each individual snake species, is imperfect in that it carries a risk of allergic reactions to livestock antibodies and can’t be used to treat a wide variety of snakes.

    That’s where the nanoparticles could come in.

    Both Shea and Gutiérrez are clear from the beginning that if this idea works, it won’t be a replacement for antivenoms. It will likely never be able to bind to each of the dozens of unique toxins, but it binds broadly to the worst of them and so could give you that extra bit of time to reach the proper antivenom.

    It would also have an indefinite shelf life and be able to be administered by anyone, anywhere. It certainly could be better than the ineffective-at-best and harmful-at-worst traditional remedies for snake bites, both experts say.

    Tourniquets are popular, but can actually cause more tissue damage, preventing blood from moving.

    Cutting the skin to remove the venom simply leads to infection – and the venom is injected far too deep to squeeze or suck out. Using stun guns doesn’t actually do anything other than also burning the wound.

    Another popular remedy – using a black stone or calcified bone at the site of the injection – isn’t harmful, but doesn’t work and often delays transportation to treatment.

    “What should be done is basically reassure the person and take them as fast as possible to the nearest health facility,” Gutiérrez says.

    Traditional remedies are popular, however, because access to antivenoms is sparse and expensive in much of the world; it could take 20 hours to reach an antivenom in Sub-Saharan Africa.

    Science to Save Lives
    While their dream is far from becoming a reality, it isn’t impossible. It faces hurdles – funding, primarily – but even that isn’t insurmountable. Shea has received a surprising amount of inquiries not from physicians or pharmaceutical companies but from zoos and film producers, veterinarians and dog lovers.

    “We’ve heard interest from that community if it is truly effective, having that in your backpack as part of your camping equipment as opposed to some of the obsolete ways, could be a component for the serious outdoorsman,” Shea says.

    He and Gutiérrez are working on international grants to help pay for additional studies hoping to eventually lead to clinical studies. The U.S. pharmaceutical market isn’t all that interested – deaths from snake bites in the U.S. are relatively few – but snake bites do affect about 2.5 million people and kill more than 100,000 people globally each year.

    Their research is attracting attention from other venom experts, people trained to be skeptical of snake oil cures for snake bites.

    “Initially, I thought it was fantasy stuff,” says Steve MacKessy, one of the country’s leading snake bite experts and a professor at the University of Northern Colorado. “But particularly when Kenneth Shea and his graduate student published a paper a few years ago, it was convincing,”

    yay science and medical advancement!
    RIP Mamba
    ----------------

    Wicked ones now on IG & FB!6292

  4. The Following 2 Users Say Thank You to Ax01 For This Useful Post:

    Bogertophis (03-06-2019),Dianne (03-06-2019)

  5. #3
    Bogertophis's Avatar
    Join Date
    04-28-2018
    Location
    USA
    Posts
    20,225
    Thanks
    28,132
    Thanked 19,791 Times in 11,826 Posts
    Cheers for science!!! Very encouraging stuff, thanks for sharing!

  6. #4
    BPnet Veteran Dianne's Avatar
    Join Date
    08-26-2018
    Location
    Virginia
    Posts
    1,298
    Thanks
    3,873
    Thanked 1,606 Times in 907 Posts
    Images: 17

    Re: Two New Methods for Helping the Fight Against Venomous Snakebites

    Interesting articles, particularly the one about delaying the effect of venom on the body.
    Other Snakes:
    Hudson 1988 1.0 Colombian rainbow; Yang 2002 1.0 Corn snake; Merlin 2000 1.0 Solomon Island ground boa; Kett 2015 1.0 Diamond Jungle Jaguar carpet python; Dakota 2014 0.0.1 Children’s python

    Ball pythons:
    Eli 1990 1.0 Normal; Buttercup 2015 1.0 Albino; Artemis 2015 0.1 Dragonfly; Orion 2015 1.0 Banana Pinstripe; Button 2018 1.0 Blue Eyed Lucy; Piper 2018 0.1 Piebald; Belle 2018 0.1 Lemonblast; Sabrina 2017 0.1 Mojave; Selene 2017 0.1 Banana Mojave; Loki 2018 1.0 Pastel Mystic Potion; Cuervo 2018 1.0 Banana Piebald; Claude 2017 1.0 Albino Pastel Spider; Penelope 2016 0.1 Lesser

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •  
Powered by vBadvanced CMPS v4.2.1